Clinical Trial Update: Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial investigating immunophenotyping in patients with metastatic renal cell carcinoma undergoing ablative therapy has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | Status: COMPLETED